Complicated urinary tract infection due to Acinetobacter

A complicated urinary tract infection due to *Acinetobacter* is a clinically significant infection of the renal or lower urinary tract caused by opportunistic, aerobic Gram-negative coccobacilli, most commonly belonging to the *Acinetobacter baumannii* complex This condition typically arises in hospitalized, critically ill, or immunocompromised patients with structural or functional urinary abnormalities, urinary instrumentation, or indwelling catheters Clinical management is often complicated b...

A complicated urinary tract infection due to *Acinetobacter* is a clinically significant infection of the renal or lower urinary tract caused by opportunistic, aerobic Gram-negative coccobacilli, most commonly belonging to the *Acinetobacter baumannii* complex

A complicated urinary tract infection due to *Acinetobacter* is a clinically significant infection of the renal or lower urinary tract caused by opportunistic, aerobic Gram-negative coccobacilli, most commonly belonging to the *Acinetobacter baumannii* complex Pathophysiologically, the organism establishes persistent mucosal or device-associated biofilms, frequently precipitating symptoms such as fever, flank pain, dysuria, and pyuria, with an elevated risk of treatment failure, tissue invasion,...

This condition typically arises in hospitalized, critically ill, or immunocompromised patients with structural or functional urinary abnormalities, urinary instrumentation, or indwelling catheters Pathophysiologically, the organism establishes persistent mucosal or device-associated biofilms, frequently precipitating symptoms such as fever, flank pain, dysuria, and pyuria, with an elevated risk of treatment failure, tissue invasion, and progression to secondary bacteremia or urosepsis

This condition typically arises in hospitalized, critically ill, or immunocompromised patients with structural or functional urinary abnormalities, urinary instrumentation, or indwelling catheters

Pathophysiologically, the organism establishes persistent mucosal or device-associated biofilms, frequently precipitating symptoms such as fever, flank pain, dysuria, and pyuria, with an elevated risk of treatment failure, tissue invasion, and progression to secondary bacteremia or urosepsis

Pathophysiologically, the organism establishes persistent mucosal or device-associated biofilms, frequently precipitating symptoms such as fever, flank pain, dysuria, and pyuria, with an elevated risk of treatment failure, tissue invasion, and progression to secondary bacteremia or urosepsis

Clinical management is often complicated by extensive intrinsic and acquired multidrug resistance profiles, particularly among carbapenem-resistant strains

Clinical management is often complicated by extensive intrinsic and acquired multidrug resistance profiles, particularly among carbapenem-resistant strains